I am/have/had
I am looking for
Advanced Filters
Found 32 clinical trials
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Oncology
-
Currently Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Background Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma. Most people with this cancer can be cured. But those who are not cured have a poor prognosis. Researchers want to add another drug to standard treatment see if it can improve the cure rate. Objective To …
r-chop regimen
gilbert's syndrome
doxorubicin
prednisone
platelet count
- 0 views
- 27 Feb, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)
are in the hospital with COVID-19. They will or will not be treated with a BTK inhibitor. They do not have COVID-19. They are or are not in the hospital. They will be treated with a BTK
SARS
coronavirus infection
covid-19
- 47 views
- 26 Feb, 2021
- 3 locations